Lipoxin A4, CAS [[89663-86-5]]

Produktübersicht

• Artikelname: Lipoxin A4, CAS [[89663-86-5]]
• Artikelnummer: MCE-HY-113509
• Hersteller Artikelnummer: HY-113509
• Alternativnummer: MCE-HY-113509-25UG,MCE-HY-113509-25UG(283.71UMX250ULINETHANOL)
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: LXA4

Produktbeschreibung

Lipoxin A4 (LXA4), an endogenous lipoxygenase-derived eicosanoid mediator, has potent dual pro-resolving and anti-inflammatory properties[1]. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes (NHEKs) associated with the ERK1/2 and NF-kB pathways[2]. Lipoxin A4 inhibits serum amyloid A (SAA)-mediated IL-8 release with an IC50 value of 25.74 nM[3].

Produkteigenschaften

• Molekulargewicht: 352.47
• Reinheit: 98.00
• CAS Nummer: [89663-86-5]
• Formel: C20H32O5
• Target-Kategorie: Endogenous Metabolite,Interleukin Related

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Natural Products